Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population

Journal of Diabetes

Volumn 7, Issue 1, 2015, Pages 102-113

  Lasram, Khaled ^a   Ben Halim, Nizar ^a   Benrahma, Houda ^b   Mediene Benchekor, Sounnia ^c   Arfa, Imen ^a   Hsouna, Sana ^a   Kefi, Rym ^a   Jamoussi, Henda ^a,d   Ben Ammar, Slim ^a   Bahri, Sonia ^a   Abid, Abdelmajid ^a,d   Benhamamouch, Soraya ^c   Barakat, Abdelhamid ^b   Abdelhak, Sonia ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b Institut Pasteur du Maroc   (Morocco)

^c UNIVERSITY OF ORAN   (Algeria)

^d Institut National de Nutrition Tunis   (Tunisia)

Author keywords

CDKAL1; Genetic association; IGF2BP2; Tunisian population; Type 2 diabetes

Indexed keywords

BINDING PROTEIN; INSULIN LIKE GROWTH FACTOR 2 MRNA BINDING PROTEIN 2; MESSENGER RNA; SOMATOMEDIN B; UNCLASSIFIED DRUG; CDKAL1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 5; IGF2BP2 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CDKAL1 GENE; COHORT ANALYSIS; CONTROL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FAMILY HISTORY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SECOND DEGREE RELATIVE; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIAN; WORLD HEALTH ORGANIZATION; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; TUNISIA;

CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE 5; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PROGNOSIS; RNA-BINDING PROTEINS; TUNISIA;

EID: 84920136626     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12147     Document Type: Article

References (48)

1. Gerich JE. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev. 1998; 19: 491-503.
2. Freeman H, Cox RD. Type-2 diabetes: A cocktail of genetic discovery. Hum Mol Genet. 2006; 15 Spec No 2: R202-209.
3. Papoz L, Achour N, Henry-Amar M, Ben Khalifa F, Eschwege E, Ben Ayed H. [Cross-sectional study of growth between 3 and 20 years of age in the population of Tunisia]. Rev Epidemiol Sante Publique. 1983; 31: 1-10.
4. Bouguerra R, Alberti H, Salem LB etal. The global diabetes pandemic: The Tunisian experience. Eur J Clin Nutr. 2007; 61: 160-165.
5. Lew J, Huang QQ, Qi Z etal. A brain-specific activator of cyclin-dependent kinase 5. Nature. 1994; 371: 423-426.
6. Wei FY, Nagashima K, Ohshima T etal. Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med. 2005; 11: 1104-1108.
7. Ahmed D, Sharma M. Cyclin-Dependent Kinase 5/p35/p39: A novel and imminent therapeutic target for diabetes mellitus. Int J Endocrinol. 2011; 2011: 530274.
8. Zeggini E, Weedon MN, Lindgren CM etal. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007; 316: 1336-1341.
9. Steinthorsdottir V, Thorleifsson G, Reynisdottir I etal. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39: 770-775.
10. Gu L, Shigemasa K, Ohama K. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer. Int J Oncol. 2004; 24: 671-678.
11. Grarup N, Rose CS, Andersson EA etal. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10, 705 Danish subjects: Validation and extension of genome-wide association studies. Diabetes. 2007; 56: 3105-3111.
12. Groenewoud MJ, Dekker JM, Fritsche A etal. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia. 2008; 51: 1659-1663.
13. Palmer ND, Goodarzi MO, Langefeld CD etal. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes. 2008; 57: 1093-1100.
14. Rodriguez S, Eiriksdottir G, Gaunt TR etal. IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res. 2010; 20: 310-318.
15. Christiansen J, Kolte AM, Hansen T, Nielsen FC. IGF2 mRNA-binding protein 2: Biological function and putative role in type 2 diabetes. J Mol Endocrinol. 2009; 43: 187-195.
16. Saxena R, Voight BF, Lyssenko V etal. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316: 1331-1336.
17. Scott LJ, Mohlke KL, Bonnycastle LL etal. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316: 1341-1345.
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553.
19. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98 (Suppl. 5): 786-806.
20. Arfa I, Abid A, Malouche D etal. Familial aggregation and excess maternal transmission of type 2 diabetes in Tunisia. Postgrad Med J. 2007; 83: 348-351.
21. Arfa I, Abid A, Nouira S etal. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst. 2008; 9: 32-36.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
23. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005; 76: 887-893.
24. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990; 11: 116-128.
25. Salanti G, Southam L, Altshuler D etal. Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol. 2009; 170: 537-545.
26. Sanghera DK, Ortega L, Han S etal. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008; 9: 59.
27. Hertel JK, Johansson S, Raeder H etal. Genetic analysis of recently identified type 2 diabetes loci in 1, 638 unselected patients with type 2 diabetes and 1, 858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia. 2008; 51: 971-977.
28. Wu Y, Li H, Loos RJ etal. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes. 2008; 57: 2834-2842.
29. Ng MC, Park KS, Oh B etal. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6, 719 Asians. Diabetes. 2008; 57: 2226-2233.
30. Rong R, Hanson RL, Ortiz D etal. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes. 2009; 58: 478-488.
31. Nemr R, Echtay A, Dashti EA etal. Strong association of common variants in the IGF2BP2 gene with type 2 diabetes in Lebanese Arabs. Diabetes Res Clin Pract. 2012; 96: 225-229.
32. Cauchi S, Meyre D, Durand E etal. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS ONE. 2008; 3: e2031.
33. Mtiraoui N, Turki A, Nemr R etal. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARgamma, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs. Diabetes Metab. 2012; 38: 444-449.
34. Cauchi S, Ezzidi I, El Achhab Y etal. European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes Metab. 2012; 38: 316-323.
35. Gu T, Horova E, Mollsten A etal. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. J Diabetes Complications. 2012; 26: 393-398.
36. Li X, Allayee H, Xiang AH etal. Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans. Obesity (Silver Spring). 2009; 17: 729-736.
37. Sjogren M, Lyssenko V, Jonsson A etal. The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia. 2008; 51: 2242-2251.
38. Webster RJ, Warrington NM, Beilby JP, Frayling TM, Palmer LJ. The longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI. BMC Med Genet. 2010; 11: 140.
39. Chistiakov DA, Nikitin AG, Smetanina SA etal. The rs11705701 G>A polymorphism of IGF2BP2 is associated with IGF2BP2 mRNA and protein levels in the visceral adipose tissue - a link to type 2 diabetes susceptibility. Rev Diabet Stud. 2012; 9: 112-122.
40. Chen G, Xu Y, Lin Y etal. Association study of genetic variants of 17 diabetes-related genes/loci and cardiovascular risk and diabetic nephropathy in the Chinese She population. J Diabetes. 2013; 5: 136-145.
41. Liu Y, Yu L, Zhang D etal. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia. 2008; 51: 2134-2137.
42. Horikoshi M, Hara K, Ito C etal. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia. 2007; 50: 2461-2466.
43. Omori S, Tanaka Y, Takahashi A etal. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes. 2008; 57: 791-795.
44. Horikawa Y, Miyake K, Yasuda K etal. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab. 2008; 93: 3136-3141.
45. Tabara Y, Osawa H, Kawamoto R etal. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes. 2009; 58: 493-498.
46. Dehwah MA, Wang M, Huang QY. CDKAL1 and type 2 diabetes: A global meta-analysis. Genet Mol Res. 2010; 9: 1109-1120.
47. Nemr R, Almawi AW, Echtay A, Sater MS, Daher HS, Almawi WY. Replication study of common variants in CDKAL1 and CDKN2A/2B genes associated with type 2 diabetes in Lebanese Arab population. Diabetes Res Clin Pract. 2012; 95: e37-e40.
48. Fu LL, Lin Y, Yang ZL, Yin YB. [Association analysis of genetic polymorphisms of TCF7L2, CDKAL1, SLC30A8, HHEX genes and microvascular complications of type 2 diabetes mellitus]. Chin J Med Genet. 2012; 29: 194-199.